Sinopharm
1099.HK
#2614
Rank
โ‚น652.94 B
Marketcap
โ‚น209.23
Share price
-1.72%
Change (1 day)
7.98%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.663 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.663 Trillion. In 2024 the company made a revenue of โ‚น7.663 Trillion a decrease over the revenue in the year 2023 that were of โ‚น8.075 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.663 T-5.1%
2023โ‚น8.075 T5.42%
2022โ‚น7.660 T-2.1%
2021โ‚น7.824 T16.85%
2020โ‚น6.696 T14.95%
2019โ‚น5.825 T21.52%
2018โ‚น4.793 T5.93%
2017โ‚น4.525 T27.22%
2016โ‚น3.557 T5.37%
2015โ‚น3.375 T9.14%
2014โ‚น3.092 T17.22%
2013โ‚น2.638 T25.94%
2012โ‚น2.094 T34.61%
2011โ‚น1.556 T55.34%
2010โ‚น1.001 T35.79%
2009โ‚น737.84 B37.56%
2008โ‚น536.38 B31.43%
2007โ‚น408.12 B40.26%
2006โ‚น290.97 B